Short-term exogenous glucocorticosteroidal effect on iron and copper status in canine leismaniasis (Leihmania infantum)

Canadian Journal of Veterinary Research

Volumn 69, Issue 4, 2005, Pages 287-292

  Adamama Moraitou, K K ^a   Saridomichelakis, M N ^a   Polizopoulou, Z ^a   Kritsepi, M ^a   Tsompanakou, A ^b   Koutinas, A F ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b G PAPANICOLAOU HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; ANTIINFLAMMATORY AGENT; COPPER; GLUCOCORTICOID; HEMOSIDERIN; IMMUNOSUPPRESSIVE AGENT; IRON; MEGLUMINE ANTIMONATE; PREDNISOLONE; TRANSFERRIN;

ARTICLE; BONE MARROW; CONTROLLED STUDY; COPPER BLOOD LEVEL; DOG; DRUG MONITORING; DRUG USE; FEMALE; HEMATOCRIT; IRON BLOOD LEVEL; LEISHMANIASIS; MALE; NONHUMAN; SHORT COURSE THERAPY;

ANIMALS; BLOOD CHEMICAL ANALYSIS; COPPER; DOG DISEASES; DOGS; FEMALE; GLUCOCORTICOIDS; HEMATOCRIT; HEMOGLOBINS; IRON; LEISHMANIA INFANTUM; LEISHMANIASIS, VISCERAL; MALE; PREDNISOLONE; RANDOM ALLOCATION;

ANIMALIA; CANIS FAMILIARIS;

EID: 28544439697     PISSN: 08309000     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Scott DW, Miller WH, Griffin CE. Glucocorticoid hormones. In: Small Animal Dermatology. Philadelphia: WB Saunders, 2001: 244-252.
2. Harvey JW, Levin DE, Chen CL. Potential effects of glucocorticoids on serum iron concentration in dogs. Vet Clin Pathol 1987; 16:46-50.
3. Smith JE. Iron metabolism in dogs and cats. Compend Cont Educ Pract Vet 1992;14:39-43.
4. Fontaine J, Neve J, Pertz A, Famaey JP. Effects of acute prednisolone administration on plasma and liver copper in rats with adjuvant arthritis. Biol Trace Elem Res 1992;32:355-360.
5. Yunice AA, Czerwinski AW, Lindeman RD. Influence of synthetic corticosteroids on plasma zinc and copper in humans. Am J Med Sci 1981;282:68-74.
6. Ferrer L. Leishmaniasis. In: Kirk RW, Bonagura JD, eds. Kirk's Current Veterinary Therapy XI. Philadelphia: WB Saunders, 1992:266-270.
7. Koutinas AF, Polizopoulou ZS, Saridomichelakis MN, Argyriadis D, Fytianou A, Plevraki K. Clinical considerations on canine visceral leishmaniasis in Greece: a retrospective study of 158 cases (1989-1996). J Am Anim Hosp Assoc 1999;35: 376-383.
8. Mauel J, Ransijn A, Buchmuller-Rouiller Y. Killing of Leishmania parasites in activated murine macrophages is based on an L-arginine-dependent process that produces nitrogen derivatives. J Leukoc Biol 1991;49:73-82.
9. Wilson ME, Vorhies RW, Andersen KA, Britigan BE. Acquisition of iron from transferrin and lactoferrin by the protozoan Leishmania chagasi. Infect Immun 1994;62:3262-3269.
10. Soteriadou K, Papavasiliou P, Voyiatzaki C, Boelaert J. Effect of iron chelation on the in-vitro growth of Leishmania promastigotes. J Antimicrob Chemother 1995;35:23-29.
11. Bergeaud P. The contribution of corticotherapy in the treatment of certain forms of canine leishmaniasis: results of series of forty-three cases. Prat Med Chirurg Anim Comp 1998;23:121-127.
12. Guidelines to the Care and Use of the Experimental Animals. Reference: Council directive 86/609/EEC of 24th of November 1986 on the approximation of Laws, regulations and administrative provisions of the Member States regarding the protection of animals used for experimental and other scientific purposes. Official Journal 1986;358:1-28.
13. Lewis LD, Morris ML, Hand MS. Small Animal Clinical Nutrition III. Topeka, Kansas: Mark Morris Associates, 1987.
14. Olsen DA, Hamlin BU. A new method for serum iron and total iron binding capacity by atomic absorption. Clin Chem 1969; 15:438-444.
15. Smith JE. Iron metabolism and its disorders. In: Kaneko JJ, Harvey JW, Bruss M, eds. Clinical Biochemistry of Domestic Animals. San Diego: Academic Press, 1997:223-239.
16. Jain NC. Essentials of Veterinary Hematology. Philadelphia: Lea and Febiger, 1993.
17. Couto CG. Clinical approach to the bleeding dog or cat. Vet Med 1999:450-459.
18. Slappendel RJ, Ferrer L. Leishmaniasis. In: Greene CE, ed. Infectious Diseases of the Dog and Cat. Philadelphia: WB Saunders, 1998:450-458.
19. Kontos VJ, Koutinas AF. Old world canine leishmaniasis. Compend Cont Educ Pract Vet 1993;15:949-960.
20. Plumb DC. Glucocorticoid agents, general information. In: Veterinary Drug Handbook. Ames: Iowa State University Press, 1999:355-358.
21. Rodes D, Acena MC, Gascon M. Etude cytologique et biochimique du fer medullaire chez les chiens atteints de leishmaniose et sa relation avec des parameters sanguines et seriques. Rev Med Vet 1999;150:965-974.
22. Couto CG. Anemia. In: Nelson RW, Couto CG, eds. Small Animal Internal Medicine. St. Louis: Mosby Year Book, 2003:1156-1169.
23. Beisel WR, Pekarek RS, Wannemacher RW Jr. The impact of infectious disease on trace-element metabolism of the host. In: Hoekstra WG, Suttie JW, Ganther HE, Mertz W, eds. Trace Element Metabolism in Animals 2. Baltimore: University Park Press, 1974:217-240.
24. Feldman BF, Kaneko JJ, Farver TB. Anemia of inflammatory disease in the dog: clinical characterization. Am J Vet Res 1981; 42:1109-1113.
25. Mahaffey EA. Disorders of iron metabolism. In: Kirk RW, ed. Current Veterinary Therapy IX. Small Animal Practice. Philadelphia: WB Saunders, 1986:521-524.
26. Feldman BF, Kaneko JJ, Farver TB. Anemia of inflammatory disease in the dog: availability of storage iron in inflammatory disease. Am J Vet Res 1981;42:586-589.
27. Liste Burillo F, Gascon Perez FM, Palacio Liese J, Acena Fabian MC. Iron status and anemia in canine leishmanisis. Rev Med Vet 1994;145:171-176.
28. Jurado RL. Iron, infections, and anemia of inflammation. Clin Infect Dis 1997;25:888-895.
29. Ferrer L. Leishmaniasis: update in diagnosis and therapy. Proc 14th Annu Cong ESVD-ECVD Pisa, Italy. 1997:33-36.
30. Smith JE, Debowes RM, Cipriano JE. Exogenous corticosteroids increase serum iron concentrations in mature horses and ponies. J Am Vet Med Assoc 1986;188:1296-1298.
31. Underwood EJ. Iron. In: Trace Elements in Human and Animal Nutrition. New York: Academic Press Inc, 1977.
32. Weeks BR, Smith JE, Northrop JK. Relationship of serum ferritin and iron concentrations and serum iron-binding capacity to nonheme iron stores in dogs. Am J Vet Res 1989;50:198-200.
33. Fisher GL. Effects of disease on serum copper and zinc values in the beagle. Am J Vet Res 1977;38:935-940.
34. Lamand M, Levieux D. Effects of infection on plasma levels of copper and zinc in ewes. Ann Rech Vet 1981;12:133-136.
35. Keen CL, Graham TW. Trace elements. In: Kaneko JJ, ed. Clinical Biochemistry of Domestic Animals. San Diego: Academic Press Inc, 1989:753-795.
36. Henkin RI. On the role of adrenocorticosteoids in the control of zinc and copper metabolism. In: Hoekstr WG, Suttie JW, Ganther HE, Mertz W, eds. Trace Element Metabolism in Animals 2. Baltimore: University Park Press, 1974:647-651.
37. Sprietsma JE. Zinc-controlled Th1/Th2 switch significantly determines development of diseases. Med Hypotheses 1997;49: 1-14.